DUBLIN–(BUSINESS WIRE)–The “Breast Biopsy Devices: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Breast Biopsy Devices estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 8.7% over the analysis period 2020-2027.
Biopsy Guidance Systems, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$1.1 Billion by the end of the analysis period.
After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Needle Based Biopsy Guns segment is readjusted to a revised 9.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $425 Million, While China is Forecast to Grow at 13.1% CAGR
The Breast Biopsy Devices market in the U.S. is estimated at US$425 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$620.6 Million by the year 2027 trailing a CAGR of 13.1% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.
Biopsy Forceps Segment to Record 6.7% CAGR
In the global Biopsy Forceps segment, USA, Canada, Japan, China and Europe will drive the 6.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$70.4 Million in the year 2020 will reach a projected size of US$107.1 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$383.4 Million by the year 2027, while Latin America will expand at a 8% CAGR through the analysis period.
Select Competitors (Total 23 Featured) –
- Aurora Imaging Technology, Inc.
- Becton, Dickinson and Company
- Becton, Dickinson and Company
- Hologic, Inc.
- Mammotome
- Planmed Oy
What`s New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Breast Biopsy Devices – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/3pi325
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
